Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Hyderabad Institute of Oncology Private Limited (“HIOPL”), which operates the Omega Hospitals oncology network, in connection with its acquisition of a majority stake in Cytecare Hospitals Private Limited (“CHPL”), a Bengaluru-based cancer care provider. The acquisition provides for a complete exit by the founders and major shareholders of CHPL, namely, Broad Street Investments Holding (Singapore) Pte. Ltd (Goldman Sachs), Gi Global Health Fund LP and Alrox Enterprises Private Limited.
This acquisition marks Omega Hospitals’ entry into the Bengaluru oncology market and forms part of its broader national expansion strategy to strengthen its presence across India. The SAM transaction team was led by Nivedita Tiwari, Partner along with Devesh Pandey, Partner; Kuhuk Jain, Principal Associate; Tweisha Mishra, Senior Associate; and Anushka Ganguli, Associate.